LumiraDx SARS-CoV-2 Ag Test - Instructions For Use
LumiraDx SARS-CoV-2 Antigen Test supports COVID-19 prevention at Rotenburg District Hospital
IJERPH | Free Full-Text | Rapid Antigen Test LumiraDxTM vs. Real Time Polymerase Chain Reaction for the Diagnosis of SARS-CoV-2 Infection: A Retrospective Cohort Study
LumiraDx – Point of Care Testing Innovators
LumiraDx Expands its Cardiovascular Testing Portfolio with CE Marking of its NT-proBNP Test and new Exclusion Claim for its D-Dimer Test
LumiraDx Instrument for Rapid Detection of SARS-CoV-2 Instrument for Rapid | Fisher Scientific
LumiraDx five-minute SARS-CoV-2 Ag Ultra Test achieves CE Marking
Test Covid 19 Ultima Generazione, Immunofluorescenza con lettura microfluidica - Farmacia Pescetto di Pegli, Genova
LumiraDx Instrument for Rapid Detection of SARS-CoV-2 Instrument for Rapid | Fisher Scientific
Test Covid 19 Ultima Generazione, Immunofluorescenza con lettura microfluidica - Farmacia Pescetto di Pegli, Genova
Sistema diagnostico point-of-care (POCT) di ultima generazione | LumiraDx (Italia)
A rapid, high-sensitivity SARS-CoV-2 nucleocapsid immunoassay to aid diagnosis of acute COVID-19 at the point of care | medRxiv
Test point-of-care | LumiraDx (Italia)
LumiraDx continues expansion of HbA1c test
LumiraDx launches C-Reactive Protein test to combat antimicrobial resistance in India, ET HealthWorld